Back

Opportunities and limitations of iPSC technology in cardiovascular disease

29 August 2017 (15:12 - 15:30)
Organised by:
Congress Presentation Part of: Cardiac regeneration and disease modelling with induced Pluripotent Stem Cells (iPSC) Stem cells and cell therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Robert Zweigerdt

Hannover Medical School, Hannover (Germany)

4 More presentations in this session

Presentation thumbnail
State of the Art: disease modelling with iPSC.
Professor P. Van Der Meer (Groningen, NL)
Slides Video
Presentation thumbnail
Human embryonic stem cell derived epicardial cells advance cardiomyocyte-based heart regeneration
Doctor J. Bargehr (University of Cambridge, GB)
Abstract
Presentation thumbnail
Human iPS cell-derived cardiac tissue (HiCT) for cardiac regenerative therapy
Doctor H. Masumoto (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Initiation of the first heart beat and its role in cardiomyocyte differentiation
Doctor R. Tyser (Cambridge, GB)
Abstract

Access the full session

Session thumbnail
Cardiac regeneration and disease modelling with induced Pluripotent Stem Cells (iPSC)

The Event

Event poster

ESC Congress 2017

29 August 2017 15:12 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources